Retina

Andre Witkin, MD

Title: Eplerenone for the Treatment of Central Serous Chorioretinopathy

Brief Summary
To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy.

Inclusion Criteria

Study Requirements
4 study visits within a 1 month period

Age Range
18 and over

Gender
Both

Payment
None

Contact: Carly Satsuma, 617-636-5489